Order Article Reprints

Michel LL, Hartkopf AD, Fasching PA, Kolberg H-C, Hadji P, Tesch H, Häberle L, Ettl J, Lüftner D, Wallwiener M, et al. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab. Cancers. 2020; 12(10):3021. https://doi.org/10.3390/cancers12103021

Michel, Laura L., Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, and et al. 2020. "Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab" Cancers 12, no. 10: 3021. https://doi.org/10.3390/cancers12103021

Michel, L. L., Hartkopf, A. D., Fasching, P. A., Kolberg, H.-C., Hadji, P., Tesch, H., Häberle, L., Ettl, J., Lüftner, D., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Volz, B., Huebner, H., Wimberger, P., Hielscher, C., Mundhenke, C., Kurbacher, C., ... Fehm, T. N. (2020). Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab. Cancers, 12(10), 3021. https://doi.org/10.3390/cancers12103021